Treatment of epilepsy in adults
121 results
1 - 100
Immunomodulatory interventions for focal epilepsy- Brivaracetam add‐on therapy for drug‐resistant epilepsy
- Cenobamate add‐on therapy for drug‐resistant focal epilepsy
- Levetiracetam add‐on for drug‐resistant focal epilepsy
- Psychological treatments for people with epilepsy
- Clonazepam add‐on therapy for drug‐resistant epilepsy
- Eslicarbazepine acetate add‐on therapy for drug‐resistant focal epilepsy
- Oxcarbazepine add-on for drug-resistant partial epilepsy: Cochrane systematic review
- Neuropsychological and psychological interventions for people with newly diagnosed epilepsy
- Polyunsaturated fatty acid supplementation for drug‐resistant epilepsy
- Acupuncture for epilepsy
- Lamotrigine add‐on therapy for drug‐resistant focal epilepsy
- Lacosamide add‐on therapy for focal epilepsy
- Pregabalin add‐on for drug‐resistant focal epilepsy
- Carbamazepine versus valproate monotherapy for epilepsy
- Topiramate add‐on therapy for drug‐resistant focal epilepsy
- Melatonin as add‐on treatment for epilepsy
- Ketogenic diets for drug‐resistant epilepsy
- Early versus late antiepileptic drug withdrawal for people with epilepsy in remission: Cochrane systematic review
- Oxcarbazepine versus phenytoin monotherapy for epilepsy: an individual participant data review: Cochrane systematic review
- Care delivery and self‐management strategies for children with epilepsy
- Carisbamate add‐on therapy for drug‐resistant focal epilepsy
- Vigabatrin add‐on therapy for drug‐resistant focal epilepsy
- Lamotrigine versus carbamazepine monotherapy for epilepsy: an individual participant data review
- Yoga for epilepsy
- Strategies for improving adherence to antiepileptic drug treatment in people with epilepsy
- Pregabalin monotherapy for epilepsy: Cochrane systematic review
- Rufinamide add‐on therapy for drug‐resistant epilepsy
- Rapid versus slow withdrawal of antiepileptic drugs
- Vigabatrin versus carbamazepine monotherapy for epilepsy
- Gabapentin add‐on treatment for drug‐resistant focal epilepsy
- Carbamazepine versus phenytoin monotherapy for epilepsy: an individual participant data review
- Phenobarbitone versus phenytoin monotherapy for epilepsy: an individual participant data review
- Immediate antiepileptic drug treatment, versus placebo, deferred, or no treatment for first unprovoked seizure
- Carbamazepine versus phenobarbitone monotherapy for epilepsy: an individual participant data review
- Stimulant and non‐stimulant drug therapy for people with attention deficit hyperactivity disorder and epilepsy
- Topiramate versus carbamazepine monotherapy for epilepsy: an individual participant data review
- Single dose oral gabapentin for established acute postoperative pain in adults
- Zonisamide for neuropathic pain in adults
- Antidepressants for people with epilepsy and depression
- Treatments for the prevention of Sudden Unexpected Death in Epilepsy (SUDEP)
- Clobazam add‐on therapy for drug‐resistant epilepsy
- Tiagabine add‐on therapy for drug‐resistant focal epilepsy
- Antiepileptic drug monotherapy for epilepsy: a network meta‐analysis of individual participant data
- Gabapentin for acute and chronic pain: Cochrane systematic review
- Clobazam monotherapy for focal or generalized seizures
- Interventions for treating brain arteriovenous malformations in adults
- Sodium valproate versus phenytoin monotherapy for epilepsy: an individual participant data review: Cochrane systematic review
- Vagus nerve stimulation for focal seizures
- Psychological and behavioural treatments for adults with non‐epileptic attack disorder
- Valproic acid and sodium valproate for neuropathic pain and fibromyalgia in adults
- Combined vitamin B6‐magnesium treatment in autism spectrum disorder
- Anti‐seizure medications for neonates with seizures
- Topical lidocaine for neuropathic pain in adults
- Desipramine for neuropathic pain in adults
- Combination pharmacotherapy for the treatment of fibromyalgia in adults
- Amitriptyline for neuropathic pain in adults
- Oxycodone for neuropathic pain in adults
- Morphine for chronic neuropathic pain in adults